Senior insider sale
Chief Operating Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$32.2K
4.96K shares
What this filing means
OTERO JOSE MANUEL plans to sell 4.96K shares of LEXEO THERAPEUTICS, INC. valued at approximately $32.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/17/2025ACC: 0001959173-25-006487
Officer· Chief Operating Officer
Since Feb 2026
4.96K
Shares to sell
$32.2K
Approx. market value
2.12K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
10/15/2025
2.12KTotal acquired2.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/15/2025 | Restricted Stock Vesting Compensation | 2.12K | — |
| Total | 2.12K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.85K
Market value
$13.3K
8/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.12K
Market value
$18.9K
10/17/2025
Total
Units
4.96K
Value
$32.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/18/2025 | 2.85K | $13.3K | — | Completed |
| Planned — Approximate Date | ||||
10/17/2025 | 2.12K | $18.9K | NASDAQ | Planned |
| Total | 4.96K | $32.2K | ||